132 related articles for article (PubMed ID: 6086470)
1. Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer.
Vass-Sørensen M; Abeler V; Berle E; Pedersen B; Davy M; Thorsby E; Norrild B
Gynecol Oncol; 1984 Jul; 18(3):349-58. PubMed ID: 6086470
[TBL] [Abstract][Full Text] [Related]
2. Immunological reactivity of human sera with individual herpes simplex proteins: a comparative study of sera from patients with preinvasive or invasive cervical cancer and from controls.
Teglbjaerg CS; Feldborg R; Norrild B
J Med Virol; 1986 Feb; 18(2):169-80. PubMed ID: 3005489
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
Christenson B; Espmark A
Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
[TBL] [Abstract][Full Text] [Related]
4. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
[No Abstract] [Full Text] [Related]
5. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
Chiphangwi JD
IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
[TBL] [Abstract][Full Text] [Related]
6. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
Seth P; Prakash SS; Ghosh D
Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
9. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment.
Vonka V; Kanka J; Hirsch I; Závadová H; Krcmár M; Suchánková A; Rezácová D; Broucek J; Press M; Domorázková E
Int J Cancer; 1984 Jan; 33(1):61-6. PubMed ID: 6319297
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer: patterns of neutralizing antibodies.
Christenson B; Espmark A
Am J Epidemiol; 1977 Apr; 105(4):296-302. PubMed ID: 192072
[TBL] [Abstract][Full Text] [Related]
11. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
Seth P; Balachandran N
Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079
[TBL] [Abstract][Full Text] [Related]
12. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
Ito H; Kurihara S; Nishimura C
Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
[No Abstract] [Full Text] [Related]
13. [Etiological role of the herpes simplex virus in causing cervical cancer].
Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
[TBL] [Abstract][Full Text] [Related]
14. Herpes-simplex-type-2-antibodies and HLA-B12 in cervical cancer.
Koenig UD; Müller N; Schneweis KE
Lancet; 1976 Oct; 2(7990):857. PubMed ID: 61533
[No Abstract] [Full Text] [Related]
15. Herpes simplex virus and human cancer. III. Search for relationship of herpes simplex antibodies and cervical dysplasia and labial neoplasia.
Rotola A; Gerna G; Di Luca D; Virgili AR; Manservigi R; Cassai E
Tumori; 1983 Apr; 69(2):83-7. PubMed ID: 6304957
[TBL] [Abstract][Full Text] [Related]
16. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
Feorino PM; Palmer EL
J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
[No Abstract] [Full Text] [Related]
17. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
Gilman SC; Docherty JJ; Clarke A; Rawls WE
Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
19. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
[TBL] [Abstract][Full Text] [Related]
20. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
Smith JW; Torres JE; Holmquist ND
Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
